These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23481506)

  • 1. Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis.
    Fukushima H; Nishio K; Asai H; Watanabe T; Seki T; Matsui H; Sugimoto M; Matsumoto M; Fujimura Y; Okuchi K
    Shock; 2013 May; 39(5):409-14. PubMed ID: 23481506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The balance between von-Willebrand factor and its cleaving protease ADAMTS13: biomarker in systemic inflammation and development of organ failure?
    Claus RA; Bockmeyer CL; Sossdorf M; Lösche W
    Curr Mol Med; 2010 Mar; 10(2):236-48. PubMed ID: 20196724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure.
    Claus RA; Bockmeyer CL; Budde U; Kentouche K; Sossdorf M; Hilberg T; Schneppenheim R; Reinhart K; Bauer M; Brunkhorst FM; Lösche W
    Thromb Haemost; 2009 Feb; 101(2):239-47. PubMed ID: 19190805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome.
    Bongers TN; Emonts M; de Maat MP; de Groot R; Lisman T; Hazelzet JA; Leebeek FW
    Thromb Haemost; 2010 Jun; 103(6):1181-7. PubMed ID: 20390223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock.
    Kremer Hovinga JA; Zeerleder S; Kessler P; Romani de Wit T; van Mourik JA; Hack CE; ten Cate H; Reitsma PH; Wuillemin WA; Lämmle B
    J Thromb Haemost; 2007 Nov; 5(11):2284-90. PubMed ID: 17764538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis.
    Matsuyama T; Uemura M; Ishikawa M; Matsumoto M; Ishizashi H; Kato S; Morioka C; Fujimoto M; Kojima H; Yoshiji H; Takimura C; Fujimura Y; Fukui H
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S27-35. PubMed ID: 17331163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
    Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
    Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma ADAMTS13 activity parallels the APACHE II score, reflecting an early prognostic indicator for patients with severe acute pancreatitis.
    Morioka C; Uemura M; Matsuyama T; Matsumoto M; Kato S; Ishikawa M; Ishizashi H; Fujimoto M; Sawai M; Yoshida M; Mitoro A; Yamao J; Tsujimoto T; Yoshiji H; Urizono Y; Hata M; Nishino K; Okuchi K; Fujimura Y; Fukui H
    Scand J Gastroenterol; 2008; 43(11):1387-96. PubMed ID: 18609162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis.
    Reuken PA; Kussmann A; Kiehntopf M; Budde U; Stallmach A; Claus RA; Bruns T
    Liver Int; 2015 Jan; 35(1):37-45. PubMed ID: 25113276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.
    Matsukawa M; Kaikita K; Soejima K; Fuchigami S; Nakamura Y; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Shimomura H; Sugiyama S; Fujimoto K; Yoshimura M; Nakagaki T; Ogawa H
    Am J Cardiol; 2007 Sep; 100(5):758-63. PubMed ID: 17719316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation.
    Uemura T; Kaikita K; Yamabe H; Soejima K; Matsukawa M; Fuchigami S; Tanaka Y; Morihisa K; Enomoto K; Sumida H; Sugiyama S; Ogawa H
    Thromb Res; 2009 May; 124(1):28-32. PubMed ID: 18996572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAMTS13 activity is decreased in a septic porcine model. Significance for glomerular thrombus deposition.
    Bockmeyer CL; Reuken PA; Simon TP; Budde U; Lösche W; Bauer M; Birschmann I; Becker JU; Marx G; Claus RA
    Thromb Haemost; 2011 Jan; 105(1):145-53. PubMed ID: 21057705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases.
    Habe K; Wada H; Ito-Habe N; Hatada T; Matsumoto T; Ohishi K; Maruyama K; Imai H; Mizutani H; Nobori T
    Thromb Res; 2012 May; 129(5):598-602. PubMed ID: 22070827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation.
    Takahashi N; Wada H; Usui M; Kobayashi T; Habe-Ito N; Matsumoto T; Uemoto S; Nobori T; Isaji S
    Thromb Res; 2013 Mar; 131(3):225-9. PubMed ID: 23266519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in plasma von Willebrand factor-cleaving protease (ADAMTS13) levels in patients with unstable angina.
    Fuchigami S; Kaikita K; Soejima K; Matsukawa M; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Nakagaki T; Sugiyama S; Ogawa H
    Thromb Res; 2008; 122(5):618-23. PubMed ID: 18295305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation of Met1606 in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure.
    De Filippis V; Lancellotti S; Maset F; Spolaore B; Pozzi N; Gambaro G; Oggianu L; Calò LA; De Cristofaro R
    Biochem J; 2012 Mar; 442(2):423-32. PubMed ID: 22091998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preserved Expression of mRNA Coding von Willebrand Factor-Cleaving Protease ADAMTS13 by Selenite and Activated Protein C.
    Ekaney ML; Bockmeyer CL; Sossdorf M; Reuken PA; Conradi F; Schuerholz T; Blaess MF; Friedman SL; Lösche W; Bauer M; Claus RA
    Mol Med; 2015 Apr; 21(1):355-63. PubMed ID: 25860876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome.
    Hugenholtz GC; Adelmeijer J; Meijers JC; Porte RJ; Stravitz RT; Lisman T
    Hepatology; 2013 Aug; 58(2):752-61. PubMed ID: 23468040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.
    Horii M; Uemura S; Uemura M; Matsumoto M; Ishizashi H; Imagawa K; Iwama H; Takeda Y; Kawata H; Nakajima T; Fujimura Y; Saito Y
    Heart Vessels; 2008 Sep; 23(5):301-7. PubMed ID: 18810578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of von Willebrand factor and ADAMTS13 determine clinical outcome after cardioversion for atrial fibrillation.
    Freynhofer MK; Bruno V; Jarai R; Gruber S; Höchtl T; Brozovic I; Farhan S; Wojta J; Huber K
    Thromb Haemost; 2011 Mar; 105(3):435-43. PubMed ID: 21136020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.